Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.

Saved in:
Bibliographic Details
Title: Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.
Authors: Hainsworth JD (AUTHOR), Spigel DR (AUTHOR), Burris HA 3rd (AUTHOR), Shipley D (AUTHOR), Farley C (AUTHOR), Macias-Perez IM (AUTHOR), Barton J (AUTHOR), Greco FA (AUTHOR)
Source: Cancer (0008543X). 5/15/2010, Vol. 116 Issue 10, p2448-2454. 7p.
Database: Academic Search Ultimate
Description
ISSN:0008543X
DOI:10.1002/cncr.25029